HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.

Abstract
Previous reports have suggested that the herbal medicine Chunghyuldan (CHD, Qingxue-dan in Chinese and Daio-Orengedokuto in Japanese) has wide-ranging biological effects, including anti-hyperlipidaemic, anti-ischaemic, anti-inflammatory and antioxidant activities. Reactive oxygen species (ROS)-mediated mitochondrial dysfunction is thought to be one of the major pathological mechanisms responsible for Parkinson's disease (PD) and may underlie the selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) that is a hallmark of this disease. In this study, we examined the neuroprotective effects of CHD in PD models produced by treatment with neurotoxins that act via ROS-mediated mitochondrial dysfunction. In an in vitro PD model using 6-hydroxydopamine, CHD applied at concentrations of 10 and 100 μg/ml exhibited significant protective effects in PC12 cells by inhibiting intracellular ROS generation. CHD applied at 10 and 100 μg/ml also prevented 6-hydroxydopamine-induced mitochondrial depolarization and elevation of caspase-3 activity. At the same doses, CHD showed regulatory effects on the haem oxygenase-1 and gp91 phagocytic oxidase which have critical roles in generating ROS. In addition, CHD protected dopaminergic neurons in a primary mesencephalic culture against MPP+ neurotoxicity. In an in vivo PD model produced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment (20 mg/kg, 4 times, i.p.), co-administration of CHD (50 mg/kg, 5 days, p.o.) ameliorated PD-like behavioural symptoms (bradykinesia) and reduced dopaminergic neuronal damage in the SNpc and striatum as measured by immunocytochemistry. These results demonstrate the neuroprotective effects of CHD in PD models that are mediated through inhibition of ROS generation and associated mitochondrial dysfunction.
AuthorsHyo Geun Kim, Mi Sun Ju, Dong-Hyun Kim, Jongki Hong, Seung-Hun Cho, Ki-Ho Cho, Wansu Park, Eunjoo H Lee, Sun Yeou Kim, Myung Sook Oh
JournalBasic & clinical pharmacology & toxicology (Basic Clin Pharmacol Toxicol) Vol. 107 Issue 6 Pg. 958-64 (Dec 2010) ISSN: 1742-7843 [Electronic] England
PMID20629656 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2010 The Authors. Basic & Clinical Pharmacology & Toxicology © 2010 Nordic Pharmacological Society.
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • Chunghyuldan
  • Drugs, Chinese Herbal
  • Neuroprotective Agents
  • Neurotoxins
  • Reactive Oxygen Species
  • 4-phenyl-1,2,3,6-tetrahydropyridine
  • Oxidopamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Caspase 3
  • Dopamine
Topics
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (analogs & derivatives, metabolism)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Caspase 3 (metabolism)
  • Cell Death
  • Cells, Cultured
  • Disease Models, Animal
  • Dopamine (metabolism)
  • Drugs, Chinese Herbal (pharmacology)
  • Male
  • Mesencephalon (cytology, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria (pathology)
  • Neurons (metabolism)
  • Neuroprotective Agents (pharmacology)
  • Neurotoxins (metabolism)
  • Oxidopamine (pharmacology)
  • PC12 Cells
  • Parkinson Disease (pathology, prevention & control)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (toxicity)
  • Substantia Nigra (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: